Growth Metrics

Exact Sciences (EXAS) Gains from Sales and Divestitures: 2010-2018

Historic Gains from Sales and Divestitures for Exact Sciences (EXAS) over the last 9 years, with Dec 2018 value amounting to $1.3 million.

  • Exact Sciences' Gains from Sales and Divestitures rose 214.88% to $3.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.8 million, marking a year-over-year increase of 214.88%. This contributed to the annual value of $1.3 million for FY2018, which is 12.85% up from last year.
  • Per Exact Sciences' latest filing, its Gains from Sales and Divestitures stood at $1.3 million for FY2018, which was up 12.85% from $1.1 million recorded in FY2017.
  • In the past 5 years, Exact Sciences' Gains from Sales and Divestitures registered a high of $1.3 million during FY2018, and its lowest value of $491,370 during FY2014.
  • Over the past 3 years, Exact Sciences' median Gains from Sales and Divestitures value was $1.1 million (recorded in 2017), while the average stood at $1.1 million.
  • Data for Exact Sciences' Gains from Sales and Divestitures shows a peak YoY spiked of 42.59% (in 2014) over the last 5 years.
  • Over the past 5 years, Exact Sciences' Gains from Sales and Divestitures (Yearly) stood at $491,370 in 2014, then climbed by 17.64% to $578,033 in 2015, then surged by 37.74% to $796,168 in 2016, then skyrocketed by 42.21% to $1.1 million in 2017, then grew by 12.85% to $1.3 million in 2018.